🚨 $SLBT
Shen Ethan PhD () reported special transactions (Non-P/S).
Shen Ethan PhD () reported special transactions (Non-P/S).
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
November 3, 2026 at 9:42 PM
🚨 $SLBT
Shen Ethan PhD () reported special transactions (Non-P/S).
Shen Ethan PhD () reported special transactions (Non-P/S).
#SLBT SL Science Holding Limited Reports First Half 2026 Financial Results
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-reports-first-half-2026-financial-gh8b7l25avfw.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-reports-first-half-2026-financial-gh8b7l25avfw.html?utm_source=stocktitan-bluesky&utm_medium=social
SL Science Holding Limited Reports First Half 2026 Financial Results
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 26, 2026 at 8:15 PM
#SLBT SL Science Holding Limited Reports First Half 2026 Financial Results
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-reports-first-half-2026-financial-gh8b7l25avfw.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-reports-first-half-2026-financial-gh8b7l25avfw.html?utm_source=stocktitan-bluesky&utm_medium=social
Small-cap stocks with declining money flow, Mon Oct 26th - #$IPST #$XNCR #$XERS #$VIOT #$TAOX #$SLBT #$PGEN #$ORIC #$NBP #$MLYS #$GAIN #$FTH #$DVLT #$CPIX #$BDSX #$AFCG #$GCTS #$SVV #$STC #$CABO - More: crystalequityresearch.com/leading-indi... - #smallcap
Leading Indicators, Monday October 26, 2026 – Crystal Equity Research
crystalequityresearch.com
October 26, 2026 at 10:26 PM
Sector spotlight: insiders are buying Health Care stocks the most right now, $10330.53B of purchases in 90 days across 131 companies.
Leading the way: $SLBT, $KOD, $ADRX.
https://www.insiderprint.com/sector/health-care?utm_source=bluesky&utm_medium=social&utm_campaign=sector
Leading the way: $SLBT, $KOD, $ADRX.
https://www.insiderprint.com/sector/health-care?utm_source=bluesky&utm_medium=social&utm_campaign=sector
Health Care stocks insiders are buying
Insider buying across Health Care stocks.
www.insiderprint.com
October 22, 2026 at 1:12 PM
Sector spotlight: insiders are buying Health Care stocks the most right now, $10330.53B of purchases in 90 days across 131 companies.
Leading the way: $SLBT, $KOD, $ADRX.
https://www.insiderprint.com/sector/health-care?utm_source=bluesky&utm_medium=social&utm_campaign=sector
Leading the way: $SLBT, $KOD, $ADRX.
https://www.insiderprint.com/sector/health-care?utm_source=bluesky&utm_medium=social&utm_campaign=sector
とうこうしたよ！
youtube.com/watch?v=SLBt...
youtube.com/watch?v=SLBt...
【カリカリ音ASMR】漫画アナログつけペン&筆【いっしょに作業用】
YouTube video by るぅ1mm
youtube.com
October 6, 2026 at 5:24 PM
とうこうしたよ！
youtube.com/watch?v=SLBt...
youtube.com/watch?v=SLBt...
🚨 $SLBT
Wang Ching-Dong (Chief Executive Officer) bought 4,545,306 shares at an average price of $2,272,653.0000 per common share. (Date: 2026-09-29)
Wang Ching-Dong (Chief Executive Officer) bought 4,545,306 shares at an average price of $2,272,653.0000 per common share. (Date: 2026-09-29)
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
October 1, 2026 at 8:53 PM
🚨 $SLBT
Wang Ching-Dong (Chief Executive Officer) bought 4,545,306 shares at an average price of $2,272,653.0000 per common share. (Date: 2026-09-29)
Wang Ching-Dong (Chief Executive Officer) bought 4,545,306 shares at an average price of $2,272,653.0000 per common share. (Date: 2026-09-29)
$10329.9B into $SLBT. CEO Wang bought 4.5M shares. Sep 29
https://watch4insider.com/filing/0001104659-26-112844
Get alerted the minute insiders file → watch4insider.com
https://watch4insider.com/filing/0001104659-26-112844
Get alerted the minute insiders file → watch4insider.com
October 1, 2026 at 10:13 PM
$10329.9B into $SLBT. CEO Wang bought 4.5M shares. Sep 29
https://watch4insider.com/filing/0001104659-26-112844
Get alerted the minute insiders file → watch4insider.com
https://watch4insider.com/filing/0001104659-26-112844
Get alerted the minute insiders file → watch4insider.com
🟢 SL Science ($SLBT) CEO Ching-Dong Wang bought 4,545,306 shares at $2,272,653.00 on Sep 29, about $10.33T.
Insiders sell for many reasons, but buy with their own money for one.
#InsiderBuying #Stocks #StockMarket
Insiders sell for many reasons, but buy with their own money for one.
#InsiderBuying #Stocks #StockMarket
Ching-Dong Wang (CEO) bought $10.33T of SL Science ($SLBT)
Form 4 filed Oct 1. Every line of the filing.
elixstocks.com
October 1, 2026 at 8:32 PM
🟢 SL Science ($SLBT) CEO Ching-Dong Wang bought 4,545,306 shares at $2,272,653.00 on Sep 29, about $10.33T.
Insiders sell for many reasons, but buy with their own money for one.
#InsiderBuying #Stocks #StockMarket
Insiders sell for many reasons, but buy with their own money for one.
#InsiderBuying #Stocks #StockMarket
ハムストリング肉ばなれの発生・再発予防へ！北里大大学院生らが開発した新テスト「MS-SLBT」に高い関心 〜 研究論文が国際学術誌IJSMで2025年最多閲覧、Best Paper Awardを受賞 〜
ハムストリング肉ばなれの発生・再発予防へ！北里大大学院生らが開発した新テスト「MS-SLBT」に高い関心 〜 研究論文が国際学術誌IJSMで2025年最多閲覧、Best Paper Awardを受賞 〜
北里大学のプレスリリース 北里大学大学院医療系研究科 博士課程2年の佐野佑斗さん（筆頭著者）、医療衛生学部の河端将司准教授（責任著者）、渡邊裕之准教授、高平尚伸教授（指導教授）らの研究グループは、ハムストリング肉ばなれ ...
sportsmania.jp
September 3, 2026 at 5:21 AM
ハムストリング肉ばなれの発生・再発予防へ！北里大大学院生らが開発した新テスト「MS-SLBT」に高い関心 〜 研究論文が国際学術誌IJSMで2025年最多閲覧、Best Paper Awardを受賞 〜
#SLBT SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-rings-nasdaq-bell-capping-an-active-first-lqnxrleudkej.html
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-rings-nasdaq-bell-capping-an-active-first-lqnxrleudkej.html
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 2, 2026 at 8:10 PM
#SLBT SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-rings-nasdaq-bell-capping-an-active-first-lqnxrleudkej.html
https://www.stocktitan.net/news/SLBT/sl-science-holding-limited-rings-nasdaq-bell-capping-an-active-first-lqnxrleudkej.html
#SLBT SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
https://www.stocktitan.net/news/SLBT/sl-science-highlights-new-fda-drug-master-file-for-gdt-cell-derived-u2z2owsm3ben.html
https://www.stocktitan.net/news/SLBT/sl-science-highlights-new-fda-drug-master-file-for-gdt-cell-derived-u2z2owsm3ben.html
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
SL Science (NASDAQ: SLBT) reported that JY BioMed, its GDT platform licensor and IP holder, has filed a new U.S. FDA Drug Master File (DMF No. 044612) covering exosomes derived from Gamma Delta T (GDT) cells. This adds to an existing DMF on GDT cells and extends FDA-filed manufacturing and quality documentation across both the cellular and cell-free exosome formats of the same core technology.According to SL Science, DMFs centralize confidential chemistry, manufacturing and controls (CMC) data that downstream regulatory submissions can reference, potentially reducing CMC-related bottlenecks for future programs. The company highlights published preclinical and independent studies indicating that GDT-derived exosomes can trigger tumor cell death, stimulate immune responses, act synergistically with radiotherapy, remain active in immunosuppressive tumor environments, and cross the blood-brain barrier, which it views as particularly relevant to its focus on glioblastoma and other brain cancers.
www.stocktitan.net
August 27, 2026 at 12:00 PM
#SLBT SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
https://www.stocktitan.net/news/SLBT/sl-science-highlights-new-fda-drug-master-file-for-gdt-cell-derived-u2z2owsm3ben.html
https://www.stocktitan.net/news/SLBT/sl-science-highlights-new-fda-drug-master-file-for-gdt-cell-derived-u2z2owsm3ben.html
#SLBT SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma
https://www.stocktitan.net/news/SLBT/sl-science-leadership-co-authors-peer-reviewed-framework-for-cziozy4b3uuo.html
https://www.stocktitan.net/news/SLBT/sl-science-leadership-co-authors-peer-reviewed-framework-for-cziozy4b3uuo.html
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma
SL Science (Nasdaq: SLBT) announced the publication of a peer-reviewed article in Biomedicines, co-authored with Taipei Medical University researchers, that proposes a rigorous clinical development framework for γδ T cell therapy in glioblastoma, an aggressive adult brain cancer. The paper goes beyond literature review to specify clinical trial designs, biological measurements, and testing conditions needed to evaluate γδ T cell therapies in future human studies.The framework emphasizes quantitative cell-tracking, serial pharmacodynamic sampling, and potency testing under realistic low-oxygen, low-glucose tumor conditions. It also supports direct, repeated delivery into the tumor cavity to address the blood-brain barrier and recommends focusing early trial endpoints on verifiable biological activity. According to SL Science, the publication aligns with its allogeneic, off-the-shelf γδ T cell platform and sets evidence standards for its future clinical programs, while noting that γδ T cell therapy in glioblastoma remains investigational and is not tied to any specific SL Science product.
www.stocktitan.net
August 11, 2026 at 12:00 PM
#SLBT SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma
https://www.stocktitan.net/news/SLBT/sl-science-leadership-co-authors-peer-reviewed-framework-for-cziozy4b3uuo.html
https://www.stocktitan.net/news/SLBT/sl-science-leadership-co-authors-peer-reviewed-framework-for-cziozy4b3uuo.html
slbt? where's the g?? all the gays are gone???
December 4, 2025 at 8:23 PM
slbt? where's the g?? all the gays are gone???
Writing a pitch deck for slbt (sailboat)
January 15, 2024 at 4:04 PM
Writing a pitch deck for slbt (sailboat)
SLBT 徹底瘋狂！
昨日收盤 +234.83% 衝到 $3.33，盤前再暴衝 +254% 至 $11.80！ 單日翻倍再翻倍，成交量爆發，市值飆升至5.38億美元！ 低流通股+突發催化劑引爆散戶狂潮！ @Stocktwits
@Robinhood
你敢追還是已上車？ #SLBT #PreMarket #Stocks
昨日收盤 +234.83% 衝到 $3.33，盤前再暴衝 +254% 至 $11.80！ 單日翻倍再翻倍，成交量爆發，市值飆升至5.38億美元！ 低流通股+突發催化劑引爆散戶狂潮！ @Stocktwits
@Robinhood
你敢追還是已上車？ #SLBT #PreMarket #Stocks
June 16, 2026 at 12:46 PM
SLBT 徹底瘋狂！
昨日收盤 +234.83% 衝到 $3.33，盤前再暴衝 +254% 至 $11.80！ 單日翻倍再翻倍，成交量爆發，市值飆升至5.38億美元！ 低流通股+突發催化劑引爆散戶狂潮！ @Stocktwits
@Robinhood
你敢追還是已上車？ #SLBT #PreMarket #Stocks
昨日收盤 +234.83% 衝到 $3.33，盤前再暴衝 +254% 至 $11.80！ 單日翻倍再翻倍，成交量爆發，市值飆升至5.38億美元！ 低流通股+突發催化劑引爆散戶狂潮！ @Stocktwits
@Robinhood
你敢追還是已上車？ #SLBT #PreMarket #Stocks
Pre-market chaos!
SLBT +200% and SUGP +196% exploding on massive volume!
Multiple small-caps up 20-45% while PRFX -30%, CUPR -27% getting crushed. Low-float penny stock frenzy continues.
@Stocktwits
@Robinhood
@YahooFinance
Who’s riding the rockets today? #PreMarket #Stocks #SLBT #SUGP
SLBT +200% and SUGP +196% exploding on massive volume!
Multiple small-caps up 20-45% while PRFX -30%, CUPR -27% getting crushed. Low-float penny stock frenzy continues.
@Stocktwits
@Robinhood
@YahooFinance
Who’s riding the rockets today? #PreMarket #Stocks #SLBT #SUGP
June 16, 2026 at 12:24 PM
Pre-market chaos!
SLBT +200% and SUGP +196% exploding on massive volume!
Multiple small-caps up 20-45% while PRFX -30%, CUPR -27% getting crushed. Low-float penny stock frenzy continues.
@Stocktwits
@Robinhood
@YahooFinance
Who’s riding the rockets today? #PreMarket #Stocks #SLBT #SUGP
SLBT +200% and SUGP +196% exploding on massive volume!
Multiple small-caps up 20-45% while PRFX -30%, CUPR -27% getting crushed. Low-float penny stock frenzy continues.
@Stocktwits
@Robinhood
@YahooFinance
Who’s riding the rockets today? #PreMarket #Stocks #SLBT #SUGP
Lionel Messi scores the 900th goal of his glittering career.
But the Argentine superstar could not prevent Inter Miami from crashing out of the CONCACAF Champions Cup
u.afp.com/SLBT
But the Argentine superstar could not prevent Inter Miami from crashing out of the CONCACAF Champions Cup
u.afp.com/SLBT
March 19, 2026 at 2:03 AM
Lionel Messi scores the 900th goal of his glittering career.
But the Argentine superstar could not prevent Inter Miami from crashing out of the CONCACAF Champions Cup
u.afp.com/SLBT
But the Argentine superstar could not prevent Inter Miami from crashing out of the CONCACAF Champions Cup
u.afp.com/SLBT
🚨 $SLBT
Wang Ching-Dong (Chief Executive Officer) initiated ownership with 333,832,129 shares upon appointment.
Wang Ching-Dong (Chief Executive Officer) initiated ownership with 333,832,129 shares upon appointment.
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
June 18, 2026 at 10:30 PM
🚨 $SLBT
Wang Ching-Dong (Chief Executive Officer) initiated ownership with 333,832,129 shares upon appointment.
Wang Ching-Dong (Chief Executive Officer) initiated ownership with 333,832,129 shares upon appointment.
🚨 $SLBT
Xu Qian () initiated ownership with 20,000 shares upon appointment.
Xu Qian () initiated ownership with 20,000 shares upon appointment.
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
June 17, 2026 at 3:11 PM
🚨 $SLBT
Xu Qian () initiated ownership with 20,000 shares upon appointment.
Xu Qian () initiated ownership with 20,000 shares upon appointment.
🚨 $SLBT
LAU JOHNSON SHUN-PONG (Vice President of Finance) filed Form 3 reporting no initial stock ownership.
LAU JOHNSON SHUN-PONG (Vice President of Finance) filed Form 3 reporting no initial stock ownership.
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
June 16, 2026 at 10:51 PM
🚨 $SLBT
LAU JOHNSON SHUN-PONG (Vice President of Finance) filed Form 3 reporting no initial stock ownership.
LAU JOHNSON SHUN-PONG (Vice President of Finance) filed Form 3 reporting no initial stock ownership.
🚨 $SLBT
Shen Ethan PhD (Chief Technology Officer) filed Form 3 reporting no initial stock ownership.
Shen Ethan PhD (Chief Technology Officer) filed Form 3 reporting no initial stock ownership.
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
June 16, 2026 at 10:49 PM
🚨 $SLBT
Shen Ethan PhD (Chief Technology Officer) filed Form 3 reporting no initial stock ownership.
Shen Ethan PhD (Chief Technology Officer) filed Form 3 reporting no initial stock ownership.
🚨 $SLBT
Liu Mingche () filed Form 3 reporting no initial stock ownership.
Liu Mingche () filed Form 3 reporting no initial stock ownership.
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
June 16, 2026 at 10:49 PM
🚨 $SLBT
Liu Mingche () filed Form 3 reporting no initial stock ownership.
Liu Mingche () filed Form 3 reporting no initial stock ownership.
🚨 $SLBT
Chen Kwo-Liang () filed Form 3 reporting no initial stock ownership.
Chen Kwo-Liang () filed Form 3 reporting no initial stock ownership.
SEC Filing: SLBT
Click to view the official SEC document.
www.sec.gov
June 16, 2026 at 10:47 PM
🚨 $SLBT
Chen Kwo-Liang () filed Form 3 reporting no initial stock ownership.
Chen Kwo-Liang () filed Form 3 reporting no initial stock ownership.